The SMC decision regarding Migalastat (Galafold) was announced on 7 November 2016. The relevant Detailed Advice Document can be found here.
The October 2016 Fabry Newsletter is now available and can be downloaded here.
Please submit your email address to receive our next newsletter.
Are you interested in sharing your experience with Fabry Disease?
Fulcrum Research Group is seeking Fabry patients… twitter.com/i/web/status/10532…
October 19, 2018 12:46 pm
Gene therapy evolution to a new era . #genetherapy #takingflight twitter.com/avrobio/status/103…
August 29, 2018 10:00 am
Fabry International Network © 2013 - All rights reserved